AU2015297347B2 - Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method - Google Patents

Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method Download PDF

Info

Publication number
AU2015297347B2
AU2015297347B2 AU2015297347A AU2015297347A AU2015297347B2 AU 2015297347 B2 AU2015297347 B2 AU 2015297347B2 AU 2015297347 A AU2015297347 A AU 2015297347A AU 2015297347 A AU2015297347 A AU 2015297347A AU 2015297347 B2 AU2015297347 B2 AU 2015297347B2
Authority
AU
Australia
Prior art keywords
mesenchymal stem
cells
human mesenchymal
stem cells
ror2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015297347A
Other languages
English (en)
Other versions
AU2015297347A1 (en
Inventor
Yumi IYOKU
Yo Mabuchi
Hideyuki Okano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purec Co Ltd
Original Assignee
Purec Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purec Co Ltd filed Critical Purec Co Ltd
Publication of AU2015297347A1 publication Critical patent/AU2015297347A1/en
Application granted granted Critical
Publication of AU2015297347B2 publication Critical patent/AU2015297347B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/10—Protein-tyrosine kinases (2.7.10)
    • C12Y207/10001—Receptor protein-tyrosine kinase (2.7.10.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2015297347A 2014-08-01 2015-07-31 Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method Active AU2015297347B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014-157367 2014-08-01
JP2014157367 2014-08-01
PCT/JP2015/071770 WO2016017795A1 (ja) 2014-08-01 2015-07-31 ヒト間葉系幹細胞の品質評価方法、及び、そのためのモノクローナル抗体

Publications (2)

Publication Number Publication Date
AU2015297347A1 AU2015297347A1 (en) 2017-01-19
AU2015297347B2 true AU2015297347B2 (en) 2021-05-27

Family

ID=55217690

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015297347A Active AU2015297347B2 (en) 2014-08-01 2015-07-31 Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method

Country Status (8)

Country Link
US (2) US20170204374A1 (enExample)
EP (1) EP3176253B1 (enExample)
JP (3) JP6850944B2 (enExample)
AU (1) AU2015297347B2 (enExample)
CA (1) CA2954245C (enExample)
ES (1) ES2927112T3 (enExample)
SG (2) SG10202005439XA (enExample)
WO (1) WO2016017795A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020423706B2 (en) * 2020-01-16 2024-10-24 Purec Co., Ltd. High-purity mesenchymal stem cells

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11293065B2 (en) 2016-03-14 2022-04-05 Aelan Cell Technologies, Inc. Compositions and methods for the quality control of stem cell preparations
WO2020205732A1 (en) * 2019-03-29 2020-10-08 The Johns Hopkins University Grid of responses indicating drug sensitivity
CN112094804B (zh) * 2019-06-18 2024-05-14 中国医学科学院基础医学研究所 一种异质性干细胞群、其制备方法及用途
US12460182B2 (en) 2019-08-19 2025-11-04 Cellaxia Inc. Cell-containing pharmaceutical composition
US20240018588A1 (en) * 2020-12-07 2024-01-18 Samsung Life Public Welfare Foundation Method for selecting mesenchymal stem cells having improved self-maintenance ability, and mesenchymal stem cells selected thereby
TW202246491A (zh) * 2021-01-29 2022-12-01 國立大學法人北海道大學 椎間盤再生用組成物
WO2022177032A1 (ja) 2021-02-19 2022-08-25 ＰｕＲＥＣ株式会社 骨疾患治療用医薬組成物
JP7368679B2 (ja) * 2021-09-01 2023-10-25 イミュニティリサーチ株式会社 細胞集団同定システム、方法、およびプログラム
CN116486909A (zh) * 2022-01-14 2023-07-25 天士力干细胞产业平台有限公司 一种干细胞质量评价系统
WO2023189485A1 (ja) 2022-03-31 2023-10-05 株式会社サイト－ファクト 間葉系幹細胞の品質評価方法
AU2024354962A1 (en) 2023-10-02 2026-03-12 National University Corporation Tokai National Higher Education And Research System Method for managing quality of stem cells by image analysis using ai
CN120322547A (zh) * 2023-10-26 2025-07-15 京东方科技集团股份有限公司 细胞培养方法、筛选方法以及间充质干细胞
WO2025187668A1 (ja) * 2024-03-06 2025-09-12 国立研究開発法人産業技術総合研究所 骨分化能判定方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070116701A1 (en) * 2005-10-31 2007-05-24 Austin Gurney Compositions and methods for diagnosing and treating cancer
US20090047287A1 (en) * 2006-02-17 2009-02-19 Wyeth Modulation of bone formation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004094641A2 (en) 2003-04-16 2004-11-04 Wyeth A novel method of modulating bone-realted activity
WO2009011546A2 (en) 2007-07-16 2009-01-22 Catholic University Industry Academic Cooperation Foundation Method for promoting the self-renewal of adult stem cells using mesenchymal stromal cells
JP2009060840A (ja) * 2007-09-06 2009-03-26 Keio Gijuku ヒト間葉系幹細胞濃縮方法
US20130209415A1 (en) 2010-06-03 2013-08-15 The Board Of Trustees Of The Leland Stanford Junior University Purified compositions of cardiovascular progenitor cells
US20120087868A1 (en) 2010-10-08 2012-04-12 Gabriele Todd Nanoparticle-loaded cells
JP2013066414A (ja) * 2011-09-22 2013-04-18 National Institute Of Advanced Industrial Science & Technology 胃前駆細胞の表面マーカー
JP6463029B2 (ja) * 2013-08-02 2019-01-30 有未 伊谷 ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び／または品質評価を行う方法
JP5924750B2 (ja) 2014-05-01 2016-05-25 ｉＨｅａｒｔ Ｊａｐａｎ株式会社 Ｃｄ８２陽性心筋前駆細胞

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070116701A1 (en) * 2005-10-31 2007-05-24 Austin Gurney Compositions and methods for diagnosing and treating cancer
US20090047287A1 (en) * 2006-02-17 2009-02-19 Wyeth Modulation of bone formation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020423706B2 (en) * 2020-01-16 2024-10-24 Purec Co., Ltd. High-purity mesenchymal stem cells

Also Published As

Publication number Publication date
AU2015297347A1 (en) 2017-01-19
US20210230553A1 (en) 2021-07-29
CA2954245C (en) 2023-07-25
CA2954245A1 (en) 2016-02-04
JP6850944B2 (ja) 2021-04-14
JPWO2016017795A1 (ja) 2017-06-22
EP3176253A4 (en) 2018-03-21
SG10202005439XA (en) 2020-07-29
EP3176253B1 (en) 2022-08-24
US11441123B2 (en) 2022-09-13
JP2020072662A (ja) 2020-05-14
WO2016017795A1 (ja) 2016-02-04
US20170204374A1 (en) 2017-07-20
JP6932390B2 (ja) 2021-09-08
ES2927112T3 (es) 2022-11-02
EP3176253A1 (en) 2017-06-07
JP2021100414A (ja) 2021-07-08
SG11201610795VA (en) 2017-02-27

Similar Documents

Publication Publication Date Title
US11441123B2 (en) Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method
JPWO2016017795A6 (ja) ヒト間葉系幹細胞の品質評価方法、ヒト間葉系幹細胞の分離、選別及び培養方法並びに増殖の早いヒト間葉系幹細胞の細胞集団
Noseda et al. PDGFRα demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium
JP6463029B2 (ja) ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び／または品質評価を行う方法
Pochampally Colony forming unit assays for MSCs
Jaksch et al. Cell cycle–dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines
Krohn et al. CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro
US10935542B2 (en) Method for identification and culture of multipotent mesenchymal stem cells with high proliferation potential
JP2018029583A (ja) 癌幹細胞集団及びその作製方法
Lee et al. Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cells
CN101613674A (zh) 猪静脉血管内皮细胞系及其建立方法
CN107034185A (zh) 一种裸鼹鼠骨髓间充质干细胞的原代分离培养方法
CN105062973B (zh) 一株携带tp53突变的hpv阴性阴茎鳞癌细胞系及其用途
Hu et al. Isolation of stem-like cells from 3-dimensional spheroid cultures
Sordi et al. Establishment, characterization and long-term culture of human endocrine pancreas-derived microvascular endothelial cells
Shehata et al. Purification of distinct subsets of epithelial cells from normal human breast tissue
Di Stefano et al. Very rapid and efficient generation of induced pluripotent stem cells from mouse pre-B cells
CN120485286B (zh) 一种永生化人毛乳头细胞系及其应用
CN118685360B (zh) 一种人源去分化脂肪肉瘤细胞系和应用
CN116445545A (zh) 双峰驼永生化成纤维细胞系的建立方法
Lee et al. Derivation and characterization of bone marrow-derived multipotent stem cells
ITUB20150463A1 (it) Metodo per l'identificazione delle microparticelle rilasciate da cellule natural-killer e loro usi relativi
JP2012196226A (ja) 癌幹細胞の培養方法、および癌幹細胞

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)